A well-known international expert in cell therapy with extensive knowledge of the industry. Dr Karnieli is the founder and CEO of Adva Biotechnology, a leading automation platform for cell and gene therapy. Dr Karnieli was the founder and former President of Atvio Biotech, a specialized cell and gene therapy innovation center which was sold to Orgenesis Inc. Former VP of Technology & Manufacturing at Pluristem Therapeutics, and the former VP medical device at Goji solutions. Dr Karnieli served as the chair of several industry committees such as the process & product development committee of the International Society for Cellular Therapies, expert member in the ISO TC276 Biotechnology standard committee and the former chair of the science and technology committee of the Alliance for Regenerative Medicine. Furthermore, Dr Karnieli serves as an advisor and board member to several of the lead cell therapy developing companies. Dr Karnieli earned his PhD on Cell and Gene Therapy in the Sackler School of Medicine of the Tel Aviv University. Furthermore, he holds an MBA from the Haifa University business management school.